Medication nonadherence costs the United States an estimated $290 billion every year, yet most efforts to address it focus on patient behavior such as better reminders and apps. However, a critical structural truth underlies this challenge: nearly half of all counties now qualify as pharmacy deserts, making it nearly impossible to improve adherence at scale. As traditional retail pharmacies close across rural and urban communities, millions of Americans face greater distances to essential medication access, and as distance increases, adherence declines.
The real drivers of nonadherence are structural, including long travel distances to reach pharmacies, inconsistent hours, limited transportation, high out-of-pocket costs, poor price transparency, fragmented provider-pharmacy communication, and lack of counseling when side effects or confusion arise. When 16 million Americans live more than an hour from the nearest pharmacy, adherence becomes both a logistical and economic challenge. Businesses and health systems are responding with infrastructure-level solutions including home delivery, same-day courier fulfillment, locker pickup, and community access hubs. Additionally, they’re exploring telepharmacy services that bring pharmacist expertise to any location and implementing predictive analytics that flag risk before refills are missed.
Telepharmacy, when designed intentionally, can reduce disparities rather than widen them. Equity-centered models provide SMS-based experiences that work on any phone, including multilingual and low-literacy interfaces, with telephone support positioned as a first-class channel and human fallback pathways existing for every digital interaction. Artificial intelligence is already redefining pharmacy workflows, reducing manual dispensing workload through intelligent verification and computer vision, and helping sift through calls, faxes, and messages so pharmacists can focus on clinical needs.
Modern analytics can identify upstream signals of risk before nonadherence occurs, including on-time fills without timely refills, new-to-therapy abandonment patterns, recent regimen changes correlated with confusion, and social determinants that correlate to risk—unlike traditional metrics that are retrospective and identify problems only after they happen.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://medcitynews.com/2026/03/myths-vs-reality-the-high-stakes-of-medication-adherence-amid-americas-expanding-pharmacy-deserts/